Catalysts combination opens doors to making useful compoundsAllbiopro2018-08-18T12:07:37+09:008월 18th, 2018|
Emergent to Acquire Specialty Vaccines Company PaxVaxAllbiopro2018-08-18T12:06:18+09:008월 18th, 2018|
FDA, NIH Look to Streamline Oversight of Gene TherapiesAllbiopro2018-08-17T01:20:00+09:008월 17th, 2018|
Export Certificates for Devices: FDA Issues Draft GuidanceAllbiopro2018-08-17T01:19:33+09:008월 17th, 2018|
Top Chinese Regulators Fired in Wake of Vaccine ScandalAllbiopro2018-08-17T01:19:07+09:008월 17th, 2018|
Health Officials Remove Special NIH Oversite Rules Governing Gene Therapy Experiments: ReportAllbiopro2018-08-17T01:18:41+09:008월 17th, 2018|
BioNTech Inks $425 Million Collaboration Deal with Pfizer to Develop mRNA-based Flu VaccinesAllbiopro2018-08-17T01:18:13+09:008월 17th, 2018|
rfxcel Enhances Pharmaceutical Track and Trace Solution for RussiaAllbiopro2018-08-17T01:17:45+09:008월 17th, 2018|
Former China FDA chief to resign over the country’s latest vaccine scandalAllbiopro2018-08-17T01:17:17+09:008월 17th, 2018|
Turnaround believer Buffett’s big Teva investment sends shares soaringAllbiopro2018-08-17T01:16:50+09:008월 17th, 2018|
Biohaven Reports Positive Early Clinical Trial Results for Anxiety DrugAllbiopro2018-08-17T01:16:23+09:008월 17th, 2018|
Teva scoffs at whistleblowers’ evidence in bid to dismiss kickbacks caseAllbiopro2018-08-17T01:15:57+09:008월 17th, 2018|
GlaxoSmithKline whacks 165 jobs as it closes skincare products plant in IrelandAllbiopro2018-08-17T01:15:29+09:008월 17th, 2018|
Regeneron and Teva’s Fasinumab Hits Primary and Secondary Endpoints in Late-Stage Sub StudyAllbiopro2018-08-17T01:15:03+09:008월 17th, 2018|
Apotex plant in India hit with third warning letter in 4 yearsAllbiopro2018-08-17T01:14:35+09:008월 17th, 2018|
Pfizer pays BioNTech $120M upfront to form mRNA flu vaccine pactAllbiopro2018-08-17T01:14:08+09:008월 17th, 2018|
